Article Content
Abstract
The aim of this study was to evaluate the CD4+ CD25+ and LAG3+ regulatory T lymphocyte subpopulations in patients with traditional cardiovascular risk factors and increased values of intima media thickness (IMT). Based on Doppler ultrasound, 41 patients with traditional cardiovascular risk factors were divided into two groups: group H-IMT (high-intima medial thickness) including 22 subjects with intima medial thickness (IMT) 1.0 mm and group L-IMT (low-intima medial thickness) including 19 patients with IMT 1.0 mm. Considering blood pressure values, two further groups were selected: group H-IMT/AH including 13 patients by arterial hypertension (AH) with IMT values 1.0 mm and group RF (risk factors) including 10 patients with normal blood pressure values and IMT 1.0 mm. Frequencies of T CD4+, T helper 17 (Th17), regulatory T CD4+ CD25+ (Tregs) and Lag3+ (LAG3 + Tregs) lymphocyte subpopulations were evaluated. A p value 0.05 was considered significant. Our results showed that Tregs and Treg/T17 ratio were significantly reduced in the H-IMT group compared with the L-IMT group (p 0.0093 and p 0.0047, respectively). Furthermore, in the HIMT/AH group, LAG3+ Tregs were significantly increased (p 0.0378) and CD4+ CD25+ Tregs significantly reduced (p 0.04398). We therefore would suggest that in patients with traditional cardiovascular risk factors, the reduction of regulatory T lymphocyte subpopulations can favour the progression of atherosclerotic disease. In this context, the increase in Lag3+ Tregs observed in hypertensive patients showing higher IMT values suggests that inflammation may induce the expression of LAG on Tregs, amplifying the pro-inflammatory mechanisms that induce carotid plaque formation.
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.
- Atherosclerosis
- Carotid artery disease
- CD4-positive T cells
- NKT cells
- Regulatory T cells
- T cells
Data Availability
No datasets were generated or analysed during the current study.
Code Availability
Not applicable.
Abbreviations
- IMT :
- Intima media thickness
- AH :
- Arterial hypertension
- Th17 :
- T helper 17
- Tregs :
- Regulatory T lymphocytes
- LAG3 + Tregs :
- Regulatory LAG3 + T lymphocytes
- CAS :
- Carotid artery stenosis
- TIA :
- Transient ischaemic attack
- Th1 :
- T helper1 lymphocytes
- MMPs :
- Matrix metalloproteinases
References
-
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2002;352:1685–95. https://doi.org/10.1056/NEJMra043430.
-
Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med. 2021;8:707529. https://doi.org/10.3389/fcvm.2021.707529.
-
Nezu T, Hosomi N. Usefulness of carotid ultrasonography for risk stratification of cerebral and cardiovascular disease. J Atheroscler Thromb. 2020. https://doi.org/10.5551/jat.RV17044.
-
Fliatova AY, Potekhina AY, Pylaeva EA, et al. The severity of internal carotid artery stenosis is associated with the circulating Th17 level. Heliyon. 2020;6:e03856. https://doi.org/10.1016/j.heliyon.2020.e03856. eCollection2020May.
-
Poznyak AV, Bezsonov EE, Popkova TV, Starodubova AV, Orekhov AN. Immunity in atherosclerosis: focusing on T and B cells. Int J Mol Sci. 2021;22:8379. https://doi.org/10.3390/ijms22168379.
-
Piconese S, Walker LSK, Dominguez-Villar M. Editorial: control of regulatory T cell stability, plasticity, and function in health and disease. Front Immunol. 2021;11:611591. https://doi.org/10.3389/fimmu.2020.611591.
-
He X, Liang B, Gu N. Th17/Treg imbalance and atherosclerosis. Dis Markers. 2020;2020:8821029. https://doi.org/10.1155/2020/8821029.
-
Kleinschnitz C, Kraft P, Dreykluft A et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679–91. https://doi.org/10.1182/blood-2012-04-426734.
-
Gagliani N, Magnani CF, Huber S, et al. Co-expression of CD49b and Lag3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46. https://doi.org/10.1038/nm.3179. Epub 2013 Apr 28.
-
Ammirati E, Cianflone D, Banfi M, et al. Circulating CD4+CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary artery stenosis. Arterioscler Thromb Vasc Biol. 2010;30:1832–41. https://doi.org/10.1161/ATVBAHA.110.206813. Epub 2010 Jun 10.
-
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S19–40. https://doi.org/10.2337/dc23-S002.
-
American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285–e350. https://doi.org/10.1016/j.jacc.2018.11.003
-
European Society of Cardiology (ESC) and European Society of Hypertension (ESH). 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
-
Hot A, Lennie V, Mussec P. Combination of IL 17 and TNF-alpha induces a proinflammatory, procoagulant e prothrombotic phenotype in human endothelial cells. Ann Rheum Dis. 2012;71:768–76. https://doi.org/10.1136/annrheumdis-2011-200468. Epub 2012 Jan 18.
-
Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–74. https://doi.org/10.1038/nature01323.
-
Liu Y, Zhang Y, Zhang H, et al. Cytokines associated with immune response in atherosclerosis. Front Immunol. 2023;14: 9556506. https://doi.org/10.3389/fimmu.2023.9556506.
-
Stubbe T, Ebner F, Richter D, et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab. 2013;33:37–47. https://doi.org/10.1038/jcbfm.2012.128. Epub 2012 Sep 12.
-
Taleb S, Romain M, Ramkhelawon B, et al. Loss of SOCS3 expression in T cells reveals a regulatory role for IL-17 in atherosclerosis. J Exp Me. 2009;206:2067–77. https://doi.org/10.1084/jem.20090545.
-
Gong F, Liu Z, Liu J, Zhou P, Liu Y, Lu X. The paradoxical role of IL-17 in atherosclerosis. Cell Immunol. 2015;297:33–9. https://doi.org/10.1016/j.cellimm.2015.05.007. Epub 2015 May 29.
-
Del Porto F, Cifani N, Proietta M, et al. Regulatory TCD4+CD25+ lymphocytes increase in symptomatic carotid artery stenosis. Ann Med. 2017;49:283–90. https://doi.org/10.1080/07853890.2016.1241427. Epub 2016 Dec 8.
-
Xu X, Li M, Jiang Y. The paradox role of regulatory T cells in ischemic stroke. Scientific World Journal. 2013;2013:174373. https://doi.org/10.1155/2013/174373.
-
Keane C, Law SC, Gould C, et al. LAG3:a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma. Blood Adv. 2020;4:1367–77. https://doi.org/10.1182/bloodadvances.2019001390.
-
Zhang Q, Chikina M, Szymczak-Workman AL, et al. LAG-3 limits regulatory T cell proliferation and function in autoimmune diabetes. Sci Immunol. 2017;2:1–21. https://doi.org/10.1126/sciimmunol.aah4569.
-
Slevin SM, Garner LC, Lahiff C et al. Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis. J Crohns Colitis 2020.https://doi.org/10.1093/ecco-jcc/jjaa054. Online ahead of print
-
Workman CJ, Cauley LS, Kim IJ, Blackman MA, Wooland DL, Vignali DA. Lymphocyte activation gene 3(CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J Immunol. 2004;172:5450–5. https://doi.org/10.4049/jimmunol.172.9.5450.
-
Del Porto F, Cifani N, Proietta M, et al. (2019) Lag3+ regulatory T lymphocytes in critical carotid artery stenosis. Clin Exp Med. 2019;19:463–8. https://doi.org/10.1007/s10238-019-00570-x.
-
Huang CT, Workman CJ, Flies D, et al. Role of LAG-3 in regulatory T cells. Immunity. 2004;21:503–13. https://doi.org/10.1016/j.immuni.2004.08.010.
-
Albert BB, de Bock M, Derraik JG, Brennan CM, Biggs JB, Hofman PL, Cutfield WS. Non-dipping and cardiometabolic profile: a study on normotensive overweight middle-aged men. Heart Lung Circ. 2016;25(12):1218–25. https://doi.org/10.1016/j.hlc.2016.04.012.
-
Tanrıverdi O, Aşkın L, Serçelik A. Association between non-dipping status and carotid intima-media thickness in patients with elevated blood pressure category. Cardiovasc Surg Int. 2020;7(2):76–83. https://doi.org/10.5606/e-cvsi.2020.845.
-
Kim JY, Lee E, Koo S, Kim CW, Kim I. Transfer of Th17 from adult spontaneous hypertensive rats accelerates development of hypertension in juvenile spontaneous hypertensive rats. Biomed Res Int. 2021:;2021: 6633825. https://doi.org/10.1155/2021/6633825. PMID: 33688497; PMCID: PMC791409.
-
Delaney JAC, Olson NC, Sitlani CM, et al. Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA). BMC Cardiovasc Disord. 2021;21:45. https://doi.org/10.1186/s12872-021-01857-2.
-
Mikolajczyk TP, Guzik TJ. Adaptative immunity and hypertension. Current Hypertens Rep. 2019;21:68. https://doi.org/10.1007/s11906-019-0971-6.
-
Albany CJ, Trevelin SC, Giganti G, Lombardi G, Scottà C. Getting to the hearth of the matter: the role of regulatory T cells (Tregs) in cardiovascular disease (CVD) and atherosclerosis. Frontier Immunol. 2019;10: 2795. https://doi.org/10.3389/fimmu.2019.02795.
-
Del Porto F, Cifani N, Proietta M, Toni D, Taurino M. MMP-12 and TIMP behaviour in symptomatic and asymptomatic critical carotid artery stenosis. J Stroke Cerebrovasc Dis. 2017;26:334–8. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.09.025. Epub 2016 Oct 13.
Funding
This work was founded by the Sapienza Università di Roma as “Progetto di Ricerca Universitaria” prot no. RM11916B5107B7E8.
Ethics declarations
Ethics Approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The study was approved by the Local Ethics Committee of “Sapienza” University of Rome – Policlinico Umberto I Hospital and Sant’Andrea Hospital (project identification code 384/17). All enrolled patients provided informed written consent to be included in the present analysis.
Consent to Participate
Informed consent was obtained from all patients for inclusion in the study.
Written Consent for Publication
All enrolled patients provided informed written consent for the publication.
Competing interests
Flavia del Porto is Section Editor and Antonio Martocchia is Section Head forfor SN Comprehensive Clinical Medicine. They have not taken part in the review or selection process of this article. The authors declare no competing interests.
Additional information
About this article
Cite this article
Del Porto, F., Cifani, N., Proietta, M. et al. Regulatory T Lymphocyte Subpopulations in the Early Stages of Carotid Artery Stenosis. SN Compr. Clin. Med. 7, 215 (2025). https://doi.org/10.1007/s42399-025-01973-6
- Received
- Revised
- Accepted
- Published
- DOI https://doi.org/10.1007/s42399-025-01973-6
Keyword
- Carotid artery disease
- Lymphocyte subpopulations
- Regulatory T lymphocytes
- Arterial hypertension